NV
NVAX
Novavax, Inc. $9.42 1M +18.3% 3M +4.3% YTD +32.1% as of 2026-09-11↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset
▲ buy ▼ sell · size ≈ trade size · earnings ● beat ● miss · ring ◯ before open ◯ after close · ─ moving averages · click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.2%
Next 1 week
+0.8%
Next 1 month
+0.2%
Seasonality
Mildly negative window
Next 30 days (to Oct 13): -1.8% median,
50% of the last 30 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 26
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.18%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.82 +0.4% · Seasonal tilt -0.2%
$53M/day volume
65% volatility
+18% 1-year
52-week range · 56% of the way up · -21% from the high
$6.20$11.97
Congressional trades in NVAX Full tracker →
1 member · 1 buys / 1 sells · $2K–$30K disclosed · latest filing Nov 5, 2020.
| SELL | $1K–$15K | |
| BUY | $1K–$15K |
Earnings Full history →
Next report 2026-11-05 (Thursday, before open, in 53 days) · EPS est. -0.18.
1-day std dev
19.2%
Finished up
42%
Biggest pop
+98.7%
Biggest drop
-29.6%
Standard deviation of the close-to-close move over the last 60 reports. History, not a forecast.
Short interest — high Full report →
Crowding
85/100
Squeeze risk
72/100
29.8% of float short
8.6 days to cover
shorts +3% last read
90th %ile of its history
as of 2026-08-31
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.